Hookipa Pharma Correlations
HOOK Stock | USD 2.15 0.15 6.52% |
The current 90-days correlation between Hookipa Pharma and Mereo BioPharma Group is 0.25 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hookipa Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hookipa Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Hookipa Pharma Correlation With Market
Modest diversification
The correlation between Hookipa Pharma and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and DJI in the same portfolio, assuming nothing else is changed.
Hookipa |
Moving together with Hookipa Stock
0.78 | ME | 23Andme Holding | PairCorr |
0.93 | VALN | Valneva SE ADR | PairCorr |
0.78 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.87 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.7 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.8 | IPSC | Century Therapeutics | PairCorr |
0.75 | MTEM | Molecular Templates | PairCorr |
0.93 | NKTX | Nkarta Inc | PairCorr |
0.78 | TPST | Tempest Therapeutics | PairCorr |
0.86 | AGL | agilon health | PairCorr |
0.79 | BACK | IMAC Holdings | PairCorr |
0.8 | CYRX | Cryoport | PairCorr |
0.66 | TCHH | Trustcash Holdings | PairCorr |
0.7 | SHG | Shinhan Financial | PairCorr |
0.77 | EC | Ecopetrol SA ADR | PairCorr |
0.69 | HYMTF | Hyundai Motor | PairCorr |
0.75 | TLK | Telkom Indonesia Tbk | PairCorr |
Moving against Hookipa Stock
0.64 | KZR | Kezar Life Sciences | PairCorr |
0.43 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.42 | RNXT | RenovoRx | PairCorr |
0.4 | MLYS | Mineralys Therapeutics, | PairCorr |
0.88 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.86 | T | ATT Inc Aggressive Push | PairCorr |
0.84 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.81 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.81 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
0.79 | HD | Home Depot | PairCorr |
0.77 | HPQ | HP Inc | PairCorr |
0.75 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.7 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
0.5 | KB | KB Financial Group | PairCorr |
0.5 | VFS | VinFast Auto Earnings Call Tomorrow | PairCorr |
0.45 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.38 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Hookipa Stock performing well and Hookipa Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hookipa Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MREO | 2.65 | (0.43) | 0.00 | (0.15) | 0.00 | 5.14 | 19.32 | |||
TERN | 3.37 | (0.50) | 0.00 | (0.29) | 0.00 | 5.68 | 34.09 | |||
PDSB | 3.33 | (0.78) | 0.00 | (0.35) | 0.00 | 7.67 | 31.83 | |||
INZY | 2.74 | (1.09) | 0.00 | (0.42) | 0.00 | 5.68 | 16.62 | |||
DAWN | 2.10 | (0.08) | (0.03) | 0.03 | 2.72 | 3.84 | 11.44 | |||
ELDN | 3.42 | 0.57 | 0.13 | (22.59) | 3.04 | 10.09 | 28.12 | |||
XFOR | 4.97 | (0.84) | 0.00 | (0.45) | 0.00 | 6.90 | 62.35 | |||
ABOS | 3.55 | (0.52) | 0.00 | (0.05) | 0.00 | 7.52 | 28.07 | |||
AMLX | 4.24 | 1.32 | 0.27 | 1.26 | 4.02 | 10.06 | 33.56 |
Hookipa Pharma Corporate Management
Lukas Flatz | CoFounder | Profile | |
Klaus Orlinger | Chief Officer | Profile | |
Reinhard Kandera | CFO Director | Profile | |
Matthew Beck | Executive Relations | Profile | |
Mark Winderlich | Chief Officer | Profile | |
Joern Aldag | CEO Director | Profile | |
Marine Popoff | Communications Mang | Profile |